“…Those organizations that have had success are encouraged to go on, but of those that have not, more and more are withdrawing effort from antivirals. This does not allow one to envisage rapid progress, but perhaps some of the compounds mentioned in this summary or in a recent, more comprehensive review 77 will, after proper evaluation, be found to be generally useful in the management or control of influenza, the common cold and herpetic infections.…”